- Correspondence to Dr Primal Kaur, Biosimilars Development, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA;
- Received 17 November 2015
- Revised 28 June 2016
- Accepted 29 June 2016
- Published online 27 July 2016.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.